Mark Coleman, Director: Axsome Therapeutics AXSM Sell · Filed 06/02

Trade details

Type: Insider sale
Amount: $1,236,910.43
Shares · price: 5,537 sh · $223.39 a share
Held after: 29,603 sh
Stock: Axsome Therapeutics AXSM
Person: Mark ColemanDirector
Trade date: 26/06/02
Filed: 26/06/02
Days to filing: 0 days

Sold 15.8% of holdings

Share of holding sold: 15.8%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 05/03~07/02

Mark Coleman's recent trades

Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 05/29
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 06/01
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$1.2M
5,537 sh
$1.2M
Filed 06/02
Traded 06/02